Norstella’s VP of thought leadership, Daniel Chancellor, was invited to share his perspectives on the proliferation of data with the leading publication The Medicine Maker. The timing was perfect, coming shortly after we launched NorstellaLinQ, the biopharma industry’s first fully integrated data asset.
The article explores various themes such as abundance, the importance of data connectivity, and aligning with the patient journey. There are also tangible examples of how our clients have addressed these challenges to improve access to new treatments. NorstellaLinQ is foundational to how we support our partners, by integrating our gold-standard proprietary market intelligence with comprehensive real-world data, all the way from pipeline to patient.
Check out the full article in The Medicine Maker here: The Role of Data in Drug Development
Learn more about NorstellaLinQ.
VP Thought Leadership | Norstella